A phase I trial of ADS-4101 for the treatment of partial onset epileptic seizures in healthy volunteers

Trial Profile

A phase I trial of ADS-4101 for the treatment of partial onset epileptic seizures in healthy volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 22 May 2017

At a glance

  • Drugs ADS 4101 (Primary) ; Lacosamide (Primary)
  • Indications Epilepsy
  • Focus Adverse reactions; Pharmacokinetics
  • Most Recent Events

    • 22 May 2017 Results published in an Adamas Pharmaceuticals media release.
    • 22 May 2017 According to an Adamas Pharmaceuticals media release, positive data from the Phase 1a trial will be presented at the 14th Antiepileptic Drug and Device Trials Conference.
    • 08 Jan 2017 According to an Adamas Pharmaceuticals media release, the company anticipates to present the trial results at an upcoming medical conference.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top